{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:25:50Z","timestamp":1783938350641,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bbrc.2019.10.177","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T17:40:21Z","timestamp":1572630021000},"page":"646-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts"],"prefix":"10.1016","volume":"521","author":[{"given":"Adrienne R.","family":"Wells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai P.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.10.177_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbrc.2019.10.177_bib2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(16)31406-4","article-title":"Hypertrophic scarring: the greatest unmet challenge after burn injury","volume":"388","author":"Finnerty","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2019.10.177_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2019.10.177_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1083\/jcb.200506179","article-title":"Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers","volume":"172","author":"Goffin","year":"2006","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2019.10.177_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/path.4104","article-title":"The myofibroblast matrix: implications for tissue repair and fibrosis","volume":"229","author":"Klingberg","year":"2013","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.bbrc.2019.10.177_bib6","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1017\/S1462399411001967","article-title":"Myofibroblast differentiation and survival in fibrotic disease","volume":"13","author":"Kis","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbrc.2019.10.177_bib7","first-page":"56","article-title":"Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar","volume":"146","author":"Desmouliere","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2019.10.177_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.10.177_bib9","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/MCB.00049-13","article-title":"Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts","volume":"33","author":"Kim","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2019.10.177_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI93563","article-title":"Resolution of organ fibrosis","volume":"128","author":"Jun","year":"2018","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2019.10.177_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1755-1536-3-16","article-title":"The multifaceted role of pirfenidone and its novel targets","volume":"3","author":"Macias-Barragan","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bbrc.2019.10.177_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/SAP.0b013e31821b6d08","article-title":"A\u00a0controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients","volume":"68","author":"Armendariz-Borunda","year":"2012","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.bbrc.2019.10.177_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/SCS.0b013e31828609cb","article-title":"Coadjuvant treatment with surgery and pirfenidone in severe facial trauma due to dog bite","volume":"24","author":"Cantu-Cantu","year":"2013","journal-title":"J.\u00a0Craniofac. Surg."},{"key":"10.1016\/j.bbrc.2019.10.177_bib14","first-page":"7340641","article-title":"Topical administration of pirfenidone increases healing of chronic diabetic foot ulcers: a randomized crossover study","author":"Janka-Zires","year":"2016","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.bbrc.2019.10.177_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41374-017-0014-3","article-title":"Pirfenidone reduces profibrotic responses in human dermal myofibroblasts, in\u00a0vitro","volume":"98","author":"Hall","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbrc.2019.10.177_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/978-1-4939-2694-7_47","article-title":"Protein detection by simple western analysis","volume":"1312","author":"Harris","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2019.10.177_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2019.10.177_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/excr.2000.4869","article-title":"Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast","volume":"257","author":"Vaughan","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2019.10.177_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fphar.2014.00131","article-title":"Integrins and cadherins as therapeutic targets in fibrosis","volume":"5","author":"Agarwal","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.10.177_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","article-title":"Diverse functions of matrix metalloproteinases during fibrosis","volume":"7","author":"Giannandrea","year":"2014","journal-title":"Discov. Model. Mech."},{"key":"10.1016\/j.bbrc.2019.10.177_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-4939-6430-7_34","article-title":"CCN2 in skin fibrosis","volume":"1489","author":"Leask","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2019.10.177_bib22","first-page":"s10","article-title":"Mechanisms of pathological scarring: role of myofibroblasts and current developments","volume":"19","author":"Sarrazy","year":"2011","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.bbrc.2019.10.177_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10753-018-0871-y","article-title":"Pirfenidone ointment modulates the burn wound bed in C57BL\/6 mice by suppressing inflammatory responses","volume":"42","author":"Medina","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.bbrc.2019.10.177_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jxb\/erh012","article-title":"From signal to cell polarity: mitogen-activated protein kinases as sensors and effectors of cytoskeleton dynamicity","volume":"55","author":"Samaj","year":"2004","journal-title":"J.\u00a0Exp. Bot."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1932087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1932087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:44:05Z","timestamp":1757763845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1932087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0006291X1932087X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.177","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}